113 related articles for article (PubMed ID: 16941073)
21. Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.
Barth RF; Kaur B
J Neurooncol; 2009 Sep; 94(3):299-312. PubMed ID: 19381449
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain.
Zhang C; Zhang F; Tsan R; Fidler IJ
Cancer Res; 2009 Feb; 69(3):828-35. PubMed ID: 19141644
[TBL] [Abstract][Full Text] [Related]
23. Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy.
Kim S; Buchlis G; Fridlender ZG; Sun J; Kapoor V; Cheng G; Haas A; Cheung HK; Zhang X; Corbley M; Kaiser LR; Ling L; Albelda SM
Cancer Res; 2008 Dec; 68(24):10247-56. PubMed ID: 19074893
[TBL] [Abstract][Full Text] [Related]
24. Combating immunosuppression in glioma.
Vega EA; Graner MW; Sampson JH
Future Oncol; 2008 Jun; 4(3):433-42. PubMed ID: 18518768
[TBL] [Abstract][Full Text] [Related]
25. Targeting transforming growth factor-beta signaling.
Pennison M; Pasche B
Curr Opin Oncol; 2007 Nov; 19(6):579-85. PubMed ID: 17906455
[TBL] [Abstract][Full Text] [Related]
26. Treatment of malignant gliomas with TGF-beta2 antisense oligonucleotides.
Hau P; Jachimczak P; Bogdahn U
Expert Rev Anticancer Ther; 2009 Nov; 9(11):1663-74. PubMed ID: 19895249
[TBL] [Abstract][Full Text] [Related]
27. TGF-β2 signaling in high-grade gliomas.
Hau P; Jachimczak P; Schlaier J; Bogdahn U
Curr Pharm Biotechnol; 2011 Dec; 12(12):2150-7. PubMed ID: 21619538
[TBL] [Abstract][Full Text] [Related]
28. TGF-beta2 inhibition augments the effect of tumor vaccine and improves the survival of animals with pre-established brain tumors.
Liu Y; Wang Q; Kleinschmidt-DeMasters BK; Franzusoff A; Ng KY; Lillehei KO
J Neurooncol; 2007 Jan; 81(2):149-62. PubMed ID: 16941073
[TBL] [Abstract][Full Text] [Related]
29. Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy.
Fakhrai H; Dorigo O; Shawler DL; Lin H; Mercola D; Black KL; Royston I; Sobol RE
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2909-14. PubMed ID: 8610141
[TBL] [Abstract][Full Text] [Related]
30. Antisense TGF-beta2 immunotherapy for hepatocellular carcinoma: treatment in a rat tumor model.
Maggard M; Meng L; Ke B; Allen R; Devgan L; Imagawa DK
Ann Surg Oncol; 2001; 8(1):32-7. PubMed ID: 11206222
[TBL] [Abstract][Full Text] [Related]
31. [Experimental study of dendritic cells transfected with cancer stem like cells RNA against 9L brain tumors].
Xiao ZY; Chen XJ; Yang Y; Xu RX
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):661-6. PubMed ID: 26284406
[TBL] [Abstract][Full Text] [Related]
32. Brain tumor therapy by combined vaccination and antisense oligonucleotide delivery with nanoparticles.
Schneider T; Becker A; Ringe K; Reinhold A; Firsching R; Sabel BA
J Neuroimmunol; 2008 Mar; 195(1-2):21-7. PubMed ID: 18304655
[TBL] [Abstract][Full Text] [Related]
33. Antisense oligonucleotides specific for transforming growth factor beta2 inhibit the growth of malignant mesothelioma both in vitro and in vivo.
Marzo AL; Fitzpatrick DR; Robinson BW; Scott B
Cancer Res; 1997 Aug; 57(15):3200-7. PubMed ID: 9242450
[TBL] [Abstract][Full Text] [Related]
34. Recombinant adenovirus-transduced dendritic cell immunization in a murine model of central nervous system tumor.
Broder H; Anderson A; Odesa SK; Kremen TJ; Liau LM
Neurosurg Focus; 2000 Dec; 9(6):e6. PubMed ID: 16817689
[TBL] [Abstract][Full Text] [Related]
35. Time course analysis and modulating effects of established brain tumor on active-specific immunotherapy.
Liu Y; Ng K; Lillehei KO
Neurosurg Focus; 2000 Dec; 9(6):e3. PubMed ID: 16817686
[TBL] [Abstract][Full Text] [Related]
36. STUDIES IN IMMUNIZATION AGAINST A TRANSPLANTABLE CEREBRAL MOUSE GLIOMA.
SCHEINBERG LC; SUZUKI K; EDELMAN F; DAVIDOFF LM
J Neurosurg; 1963 Apr; 20():312-7. PubMed ID: 14186040
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
